Erratum: Foot-and-mouth disease virus viroporin 2B antagonizes RIG-I-mediated antiviral effects by inhibition of its protein expression (Journal of Virology (2016) 90:24 (11106-11121) DOI: 10.1128/JVI.01310-16);Foot-and-mouth disease virus viroporin 2B antagonizes RIG-I-mediated antiviral effects by inhibition of its protein expression

Journal of Virology

Volumn 90, Issue 24, 2016, Pages 11106-11121

  Zhu, Zixiang ^a   Wang, Guoqing ^a   Yang, Fan ^a   Cao, Weijun ^a   Mao, Ruoqing ^a   Du, Xiaoli ^a   Zhang, Xiangle ^a   Li, Chuntian ^a   Li, Dan ^a   Zhang, Keshan ^a   Shu, Hongbing ^b   Liu, Xiangtao ^a   Zheng, Haixue ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2B PROTEIN; 3C PROTEINASE; EUKARYOTIC TRANSLATION INITIATION FACTOR 4 GAMMA; INITIATION FACTOR; PROTEINASE; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; VIRAL PROTEIN; VIROPORIN 2B; VIRUS ENZYME; 3C PROTEASES; CYSTEINE PROTEINASE; INITIATION FACTOR 4G; LEADER PROTEINASE, FOOT-AND-MOUTH DISEASE VIRUS; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; COXSACKIEVIRUS A16; EMBRYO; ENCEPHALOMYOCARDITIS VIRUS; ENTEROVIRUS 71; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENETIC TRANSCRIPTION; HOST CELL; HUMAN; HUMAN CELL; NEWBORN; NONHUMAN; PICORNAVIRIDAE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS REPLICATION; ANIMAL; CELL LINE; CRICETULUS; CRISPR CAS SYSTEM; ENTEROVIRUS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PIG; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CRICETULUS; CRISPR-CAS SYSTEMS; CYSTEINE ENDOPEPTIDASES; DEAD BOX PROTEIN 58; ENCEPHALOMYOCARDITIS VIRUS; ENDOPEPTIDASES; ENTEROVIRUS; ENTEROVIRUSES, PORCINE; EPITHELIAL CELLS; EUKARYOTIC INITIATION FACTOR-4G; FOOT-AND-MOUTH DISEASE VIRUS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEIN BINDING; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; SWINE; VIRAL PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 85000925772     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00545-21     Document Type: Erratum

References (52)

1. Alexandersen S, Mowat N. 2005. Foot-and-mouth disease: host range and pathogenesis. Foot Mouth Dis Virus 288:9-42. http://dx.doi.org/10.1007/3-540-27109-0_2.
2. Grubman MJ, Baxt B. 2004. Foot-and-mouth disease. Clin Microbiol Rev 17:465-493. http://dx.doi.org/10.1128/CMR.17.2.465-493.2004.
3. pol) in vitro. J Virol 79:7698-7706. http://dx.doi.org/10.1128/JVI.79.12.7698-7706.2005.
4. Moffat K, Howell G, Knox C, Belsham GJ, Monaghan P, Ryan MD, Wileman T. 2005. Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport. J Virol 79: 4382-4395. http://dx.doi.org/10.1128/JVI.79.7.4382-4395.2005.
5. Moffat K, Knox C, Howell G, Clark SJ, Yang H, Belsham GJ, Ryan M, Wileman T. 2007. Inhibition of the secretory pathway by foot-and-mouth disease virus 2BC protein is reproduced by coexpression of 2B with 2C, and the site of inhibition is determined by the subcellular location of 2C. J Virol 81:1129-1139. http://dx.doi.org/10.1128/JVI.00393-06.
6. Moraes MP, Diaz-San Segundo F, Dias CC, Pena L, Grubman MJ. 2011. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response. Vaccine 29:9431-9440. http://dx.doi.org/10.1016/j.vaccine.2011.10.037.
7. Jecht M, Probst C, Gauss-Muller V. 1998. Membrane permeability induced by hepatitis A virus proteins 2B and 2BC and proteolytic processing of HAV 2BC. Virology 252:218-227. http://dx.doi.org/10.1006/viro.1998.9451.
8. Doedens JR, Kirkegaard K. 1995. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J 14:894-907.
9. van Kuppeveld FJ, Hoenderop JG, Smeets RL, Willems PH, Dijkman HB, Galama JM, Melchers WJ. 1997. Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release. EMBO J 16:3519-3532. http://dx.doi.org/10.1093/emboj/16.12.3519.
10. Matsumiya T, Stafforini DM. 2010. Function and regulation of retinoic acid-inducible gene-I. Crit Rev Immunol 30:489-513. http://dx.doi.org /10.1615/CritRevImmunol.v30.i6.10.
11. Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, Grigorov B, Gerlier D, Cusack S. 2011. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147:423-435 http://dx.doi.org/10.1016/j.cell.2011.09.039.
12. Sadler AJ, Williams BR. 2008. Interferon-inducible antiviral effectors. Nat Rev Immunol 8:559-568. http://dx.doi.org/10.1038/nri2314.
13. Rice GI, Duany YD, Jenkinson EM, Forte GMA, Anderson BH, Ariaudo G, Bader-Meunier B, Baildam EM, Battini R, Beresford MW, Casarano M, Chouchane M, Cimaz R, Collins AE, Cordeiro NJV, Dale RC, Davidson JE, De Waele L, Desguerre I, Faivre L, Fazzi E, Isidor B, Lagae L, Latchman AR, Lebon P, Li CM, Livingston JH, Lourenco CM, Mancardi MM, Masurel-Paulet A, McInnes LB, Menezes MP, Mignot C, O'Sullivan J, Orcesi S, Picco PP, Riva E, Robinson RA, Rodriguez D, Salvatici E, Scott C, Szybowska M, Tolmie JL, Vanderver A, Vanhulle C, Vieira JP, Webb K, Whitney RN, Williams SG, Wolfe LA, Zuberi SM, Hur S, Grow YJ. 2014. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet 46:503-509. http://dx.doi.org/10.1038/ng.2933.
14. Ahmad S, Hur S. 2015. Helicases in antiviral immunity: dual properties as sensors and effectors. Trends Biochem Sci 40:576-585. http://dx.doi.org /10.1016/j.tibs.2015.08.001.
15. Schmidt A, Endres S, Rothenfusser S. 2011. Pattern recognition of viral nucleic acids by RIG-I-like helicases. J Mol Med 89:5-12. http://dx.doi.org /10.1007/s00109-010-0672-8.
16. Yoneyama M, Fujita T. 2010. Recognition of viral nucleic acids in innate immunity. Rev Med Virol 20:4-22. http://dx.doi.org/10.1002/rmv.633.
17. Feng Q, Hato SV, Langereis MA, Zoll J, Virgen-Slane R, Peisley A, Hur S, Semler BL, van Rij RP, van Kuppeveld FJM. 2012. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Reports 2:1187-1196. http://dx.doi.org/10.1016/j.celrep.2012.10.005.
18. Deddouche S, Goubau D, Rehwinkel J, Chakravarty P, Begum S, Maillard PV, Borg A, Matthews N, Feng Q, van Kuppeveld FJM, Sousa CRE. 2014. Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells. eLife 3:e01535. http://dx.doi.org/10.7554 /eLife.01535.
19. Barral PM, Sarkar D, Fisher PB, Racaniello VR. 2009. RIG-I is cleaved during picornavirus infection. Virology 391:171-176. http://dx.doi.org /10.1016/j.virol.2009.06.045.
20. Feng Q, Langereis MA, Olagnier D, Chiang C, van de Winkel R, van Essen P, Zoll J, Hiscott J, van Kuppeveld FJM. 2014. Coxsackievirus cloverleaf RNA containing a 5= triphosphate triggers an antiviral response via RIG-I activation. PLoS One 9:e95927. http://dx.doi.org/10.1371 /journal.pone.0095927.
21. Buskiewicz IA, Koenig A, Huber SA, Budd RC. 2012. Caspase-8 and FLIP regulate RIG-I/MDA5-induced innate immune host responses to picornaviruses. Future Virol 7:1221-1236. http://dx.doi.org/10.2217/fvl.12.115.
22. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Sousa CRE, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. http://dx.doi.org/10.1038/nature04734.
23. Zheng H, Guo J, Jin Y, Yang F, He J, Lv L, Zhang K, Wu Q, Liu X, Cai X. 2013. Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development. PLoS One 8:e55228. http://dx.doi.org/10.1371/journal.pone.0055228.
24. Lei CQ, Zhong B, Zhang Y, Zhang J, Wang SA, Shu HB. 2010. Glycogen synthase kinase 3 beta regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity 33:878-889. http://dx.doi.org/10.1016/j.immuni.2010.11.021.
25. Zhou Q, Lin H, Wang S, Wang S, Ran Y, Liu Y, Ye W, Xiong X, Zhong B, Shu HB, Wang YY. 2014. The ER-associated protein ZDHHC1 is a positive regulator of DNA virus-triggered, MITA/STING-dependent innate immune signaling. Cell Host Microbe 16:450-461. http://dx.doi.org /10.1016/j.chom.2014.09.006.
26. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339:819-823. http://dx.doi.org/10.1126 /science.1231143.
27. Li D, Yang W, Yang F, Liu H, Zhu Z, Lian K, Lei C, Li S, Liu X, Zheng H. 2016. The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-γ signaling pathway. FASEB J 30:1757-1766. http://dx.doi.org/10.1096/fj.15-281410.
28. Zhu ZX, Shi ZX, Yan WJ, Wei JC, Shao DH, Deng XF, Wang SH, Li BB, Tong GZ, Ma ZY. 2013. Nonstructural protein 1 of influenza A virus interacts with human guanylate-binding protein 1 to antagonize antiviral activity. PLoS One 8:e55920. http://dx.doi.org/10.1371/journal.pone.0055920.
29. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C-T method. Nat Protoc 3:1101-1108. http://dx.doi.org/10.1038/nprot.2008.73.
30. Fuchsluger TA, Jurkunas U, Kazlauskas A, Dana R. 2011. Corneal endothelial cells are protected from apoptosis by gene therapy.HumGene Ther 22:549-558. http://dx.doi.org/10.1089/hum.2010.079.
31. Yang X, Ouyang HS, Chen FW, Pang DX, Dong MC, Yang SS, Liu XY, Peng ZY, Wang F, Zhang X, Ren LZ. 2014. HMG-CoA reductase is negatively associated with PCV2 infection and PCV2-induced apoptotic cell death. J Gen Virol 95:1330-1337. http://dx.doi.org/10.1099/vir.0.063644-0.
32. Zhu ZX, Wei JC, Shi ZX, Yang YF, Shao DH, Li BB, Wang XD, Ma ZY. 2013 Identification of human guanylate-binding protein 1 gene (hGBP1) as a direct transcriptional target gene of p53. Biochem Biophys Res Commun 436:204-211. http://dx.doi.org/10.1016/j.bbrc.2013.05.074.
33. Wang Y, Wang X, Li J, Zhou Y, Ho W. 2013. RIG-I activation inhibits HIV replication in macrophages. J Leukoc Biol 94:337-341. http://dx.doi.org/10.1189/jlb.0313158.
34. de Los Santos T, de Avila Botton S, Weiblen R, Grubman MJ. 2006. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J Virol 80:1906-1914. http://dx.doi.org/10.1128/JVI.80.4.1906-1914.2006.
35. Foeger N, Kuehnel E, Cencic R, Skern T. 2005. The binding of foot-andmouth disease virus leader proteinase to eIF4GI involves conserved ionic interactions. FEBS J 272:2602-2611. http://dx.doi.org/10.1111/j.1742-4658.2005.04689.x.
36. Kirchweger R, Ziegler E, Lamphear BJ, Waters D, Liebig HD, Sommergruber W, Sobrino F, Hohenadl C, Blaas D, Rhoads RE. 1994. Footand-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J Virol 68:5677-5684.
37. Hüsser L, Alves MP, Ruggli N, Summerfield A. 2011. Identification of the role of RIG-I, MDA-5 and TLR3 in sensing RNA viruses in porcine epithelial cells using lentivirus-driven RNA interference. Virus Res 159:9-16 http://dx.doi.org/10.1016/j.virusres.2011.04.005.
38. Sato S, Li K, Kameyama T, Hayashi T, Ishida Y, Murakami S, Watanabe T, Iijima S, Sakurai Y, Watashi K, Tsutsumi S, Sato Y, Akita H, Wakita T, Rice CM, Harashima H, Kohara M, Tanaka Y, Takaoka A. 2015. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity 42:123-132. http://dx.doi.org/10.1016/j.immuni.2014.12.016.
39. Weber M, Sediri H, Felgenhauer U, Binzen I, Banfer S, Jacob R, Brunotte L, Garcia-Sastre A, Schmid-Burgk JL, Schmidt T, Hornung V, Kochs G, Schwemmle M, Klenk HD, Weber F. 2015. Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. Cell Host Microbe 17:309-319. http://dx.doi.org/10.1016/j.chom.2015.01.005.
40. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG, Gale M. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82:335-345. http://dx.doi.org/10.1128/JVI.01080-07.
41. Ao D, Sun SQ, Guo HC. 2014. Topology and biological function of enterovirus nonstructural protein 2B as a member of the viroporin family. Vet Res 45:87. http://dx.doi.org/10.1186/s13567-014-0087-6.
42. de Jong AS, de Mattia F, Van Dommelen MM, Lanke K, Melchers WJG, Willems PHGM, van Kuppeveld FJM. 2008. Functional analysis of picornavirus 2B proteins: effects on calcium homeostasis and intracellular protein trafficking. J Virol 82:3782-3790. http://dx.doi.org/10.1128/JVI.02076-07.
43. Liu Y, Zhu Z, Zhang M, Zheng H. 2015. Multifunctional roles of leader protein of foot-and-mouth disease viruses in suppressing host antiviral responses. Vet Res 46:127. http://dx.doi.org/10.1186/s13567-015-0273-1.
44. Wang D, Fang L, Li K, Zhong H, Fan J, Ouyang C, Zhang H, Duan E, Luo R, Zhang Z, Liu X, Chen H, Xiao S. 2012. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. J Virol 86:9311-9322. http://dx.doi.org/10.1128/JVI.00722-12.
45. Lawrence P, Schafer EA, Rieder E. 2012. The nuclear protein Sam68 is cleaved by the FMDV 3C protease redistributing Sam68 to the cytoplasm during FMDV infection of host cells. Virology 425:40-52. http://dx.doi.org/10.1016/j.virol.2011.12.019.
46. Belsham GJ, McInerney GM, Ross-Smith N. 2000. Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. J Virol 74:272-280. http://dx.doi.org/10.1128/JVI.74.1.272-280.2000.
47. Glaser W, Skern T. 2000. Extremely efficient cleavage of eIF4G by picornaviral proteinases L and 2A in vitro. FEBS Lett 480:151-155. http://dx.doi.org/10.1016/S0014-5793(00)01928-1.
48. Ao D, Guo HC, Sun SQ, Sun DH, Fung TS, Wei YQ, Han SC, Yao XP, Cao SZ, Liu DX, Liu XT. 2015. Viroporin activity of the foot-and-mouth disease virus nonstructural 2B protein. PLoS One 10:e0125828. http://dx.doi.org/10.1371/journal.pone.0125828.
49. Han SC, Guo HC, Sun SQ, Jin Y, Wei YQ, Feng X, Yao XP, Cao SZ, Xiang Liu D, Liu XT. 2016. Productive entry of foot-and-mouth disease virus via macropinocytosis independent of phosphatidylinositol 3-kinase. Sci Rep 6:19294. http://dx.doi.org/10.1038/srep19294.
50. Wagner GG, McVicar JW. 1970. Foot-and-mouth disease virus antibodies: comparison of a tissue culture microneutralization test with the assay in suckling mice. Appl Microbiol 20:995-997.
51. Van Kuppeveld, FJ, Melchers WJ, Kirkegaard K, Doedens JR. 1997. Structure-function analysis of coxsackie B3 virus protein 2B. Virology 227:111-118. http://dx.doi.org/10.1006/viro.1996.8320.
52. Harris JR, Racaniello VR. 2005. Amino acid changes in proteins 2B and 3A mediate rhinovirus type 39 growth in mouse cells. J Virol 79:5363-5373 http://dx.doi.org/10.1128/JVI.79.9.5363-5373.2005.